Individuals with type 2 diabetes who are looking to manage both their diabetes and weight may also be suitable candidates for semaglutide, as it can help regulate blood sugar levels, while promoting weight loss
In low doses it can calm your nerves
Key lipid changes with GLP-1 receptor agonists include: Triglycerides: 15-25% reduction Total cholesterol: 3-8% reduction LDL cholesterol: 3-7% reduction HDL cholesterol: 2-5% increase Non-HDL cholesterol: 5-10% reduction The SELECT cardiovascular outcomes trial demonstrated that semaglutide 2.4 mg reduced major adverse cardiovascular events by 20% in patients with established cardiovascular disease who were receiving standard background care
doi: 10.1210/clinem/dgag051
Stay away from stimulant fat burners, so-called natural GLP-1 boosters, and blood sugar blends, unless your healthcare provider says its okay
Understanding the relationship between vial concentration, injection volume, and target dose is essential for proper reconstitution and administration